749932-17-0

Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-1-difluoromethyl-2-fluorobenzene is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to be incorporated into complex organic compounds, contributing to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Bromo-1-difluoromethyl-2-fluorobenzene is employed as a building block in the creation of agrochemicals, such as pesticides and herbicides, due to its reactivity and potential to form effective active ingredients.
Used in Organic Synthesis:
4-Bromo-1-difluoromethyl-2-fluorobenzene is utilized as a reagent in organic synthesis, enabling the formation of a wide range of organic compounds for various applications, including the production of specialty chemicals and materials.
Used as a Reference Standard in Analytical Chemistry:
4-BROMO-1-DIFLUOROMETHYL-2-FLUOROBENZENE serves as a reference standard in analytical chemistry, allowing for the accurate measurement and identification of other substances in various chemical analyses, ensuring the reliability and precision of experimental results.

InChI:InChI=1/C7H4BrF3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,7H

Upstream product

• 57848-46-1 4-bromo-2-fluorobenzaldehyde 

Downstream Products

• 749932-18-1 1-cyclopentyl-3-[4-(difluoromethyl)-3-fluorophenyl]propan-1-one 
• 445303-65-1 2-[3-(difluoromethyl)-4-fluoro-phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1354286-94-4 N-(5-(4-(difluoromethyl)-3-fluorophenyl)-2-morpholinopyridin-4-yl)-5,7-difluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-amine 
• 1310949-75-7 2-(4-(difluoromethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 

Relevant academic research and scientific papers

HYDROXY ISOXAZOLE COMPOUNDS USEFUL AS GPR120 AGONISTS

The present invention relates to a compound represented by formula (I) : and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, NASH, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME

The invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula (I), and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula (I). The invention also relates to methods of preparing the compounds of formula (I).